Position in INSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$123,679
New position
Shares Held
1,160
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#496
of 663 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in INSM
reported options exposure · as of Jun 30, 2026CallValue
$533,100
CallShares
5,000
PutValue
$533,100
PutShares
5,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Limestone Investment Advisors LP holds $1,723,208 across 4 Biotechnology names. INSM ranks #2 (7.2% of the industry book) .
All Filings in INSM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $533,100 | 5,000 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $123,679 | 1,160 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $533,100 | 5,000 | Call | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||